Threshold aggregate liquidity of the related party.

No definition available.

Name:	nrxp_LicenseAgreementThresholdAggregateLiquidity
Namespace Prefix:	nrxp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Number of consecutive trading days required of minimum equity met for the transfer of assets from a related party to the Company.

+ References

No definition available.

+ Details

Name:	nrxp_MinimumEquityRequiredForTransferOfAssetsFromRelatedPartyNumberOfConsecutiveTradingDays
Namespace Prefix:	nrxp_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of trading days required of minimum equity met for the transfer of assets from a related party to the Company.

+ References

No definition available.

+ Details

Name:	nrxp_MinimumEquityRequiredForTransferOfAssetsFromRelatedPartyNumberOfTradingDays
Namespace Prefix:	nrxp_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The minimum value of equity required for the transfer of assets from related parties to the Company.

+ References

No definition available.

+ Details

Name:	nrxp_MinimumEquityValueRequiredForTransferOfAssets
Namespace Prefix:	nrxp_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of shares shall have restrictions removed on new drug application date.

+ References

No definition available.

+ Details

Name:	nrxp_NumberOfSharesRestrictionsRemovedOnNewDrugApplicationDate
Namespace Prefix:	nrxp_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of shares will have restrictions removed on new drug approval date.

+ References

No definition available.

+ Details

Name:	nrxp_NumberOfSharesRestrictionsRemovedOnNewDrugApprovalDate
Namespace Prefix:	nrxp_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of consulting fee payable per month under related party transactions.

+ References

No definition available.

+ Details

Name:	nrxp_RelatedPartyTransactionConsultingFeePayablePerMonth
Namespace Prefix:	nrxp_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of performance-based annual bonus with a minimum target payable under related party transaction.

+ References

No definition available.

+ Details

Name:	nrxp_RelatedPartyTransactionsPerformanceBasedAnnualBonusMinimumTarget
Namespace Prefix:	nrxp_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(15)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1

+ Details

Name:	us-gaap_AccountsPayableCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of transactions with related party during the financial reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-3

+ Details

Name:	us-gaap_RelatedPartyTransactionAmountsOfTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_PlanNameAxis=nrxp_TwoThousandSixteenOmnibusPlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nrxp_FormerChiefExecutiveOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nrxp_ChiefExecutiveOfficerSonMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	nrxp_AgreementAxis=nrxp_GlytechAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	nrxp_AgreementAxis=nrxp_PilltrackerSowMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Related Party Transactions (Details) $ in Millions			3 Months Ended		9 Months Ended
Related Party Transactions (Details) $ in Millions	Mar. 29, 2023 shares	Nov. 06, 2022 USD ($) D	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	May 29, 2023 USD ($)	Dec. 31, 2022 USD ($)
Related Party Transaction [Line Items]
Minimum equity required for transfer of Excluded Technology		$ 50.0
Number of consecutive trading days \| D		20
Number of trading days \| D		20
Threshold aggregate liquidity of the related party							$ 0.6
Consulting fee payable per month							0.1
Performance based annual bonus minimum target							$ 0.3
2016 Omnibus Incentive Plan
Related Party Transaction [Line Items]
Shares granted \| shares	500,000
Number of shares, restrictions removed on new drug application date \| shares	(250,000)
Number of shares, restrictions removed on new drug approval date \| shares	(250,000)
Former CEO
Related Party Transaction [Line Items]
Payment to related party			$ 0.2	$ 0.2	$ 0.7	$ 0.7
Chief Executive Officer Son [Member]
Related Party Transaction [Line Items]
Payment to related party			0.1		0.1	0.1
Chief Executive Officer Son [Member] \| Maximum
Related Party Transaction [Line Items]
Payment to related party				0.1
Related Party [Member] \| Maximum
Related Party Transaction [Line Items]
Accounts payable due to related parties			0.1		0.1			$ 0.1
Glytech Agreement [Member]
Related Party Transaction [Line Items]
Payment to related party			$ 0.1	$ 0.1	0.2	0.2
PillTracker SOW
Related Party Transaction [Line Items]
Payment to related party					$ 0.0	$ 0.2